Skip to main content
. 2019 Apr;95(4):408–417. doi: 10.1124/mol.118.115048

TABLE 1.

Functional characteristics of GABAA receptor mutants

Receptor
GABA EC50 [95% CI (n)] GABA Efficacy ± S.D.
IPTX/IGABAmax ± S.D.
µM
α1β3γ2L 59 [53–66 (n = 3)] 0.88 ± 0.024 (n = 5) <0.001 (n = 3)
M2-15′
 α1S270Iβ3γ2L 2.3 [2.1–2.6 (n = 3)] 0.78 ± 0.054 (n = 6) 0.020 ± 0.0072 (n = 3)
 α1β3N265Mγ2L 141 [128–156 (n = 3)] 0.75 ± 0.024 (n = 4) <0.001 (n = 3)
 α1β3γ2LS280W 29 [24–35 (n = 4)] 0.70 ± 0.053 (n = 3) 0.015 ± 0.0043 (n = 3)
M3-36′
 α1A291Wβ3γ2L 0.37 [0.27–0.52 (n = 3)] 0.99 ± 0.036 (n = 6) 0.10 ± 0.014 (n = 3)
 α1β3M286Wγ2L 5.9 [4.5–7.7 (n = 4)] 0.96 ± 0.032 (n = 5) 0.061 ± 0.034 (n = 5)
 α1β3γ2LS301W 43 [32–58 (n = 3)] 0.84 ± 0.054 (n = 7) 0.078 ± 0.0088 (n = 3)

CI, confidence interval.